# Alnylam Pharmaceuticals: Dawn score and attention ranking

Alnylam Pharmaceuticals scores 42 out of 100 on the Dawn Index, built from 4 signals. It ranks #7 of 9 in Health Care (Nasdaq-100), #80 of 91 in Nasdaq-100.

## What drives the Alnylam Pharmaceuticals Dawn score?

| Signal | Weight | Score (0 to 100) |
| --- | --- | --- |
| Search scale | 20% | 38 |
| Search momentum | 20% | 34 |
| Site scale | 15% | 37 |
| Site momentum | 10% | 64 |

## How does Alnylam Pharmaceuticals compare in Health Care (Nasdaq-100)?

| Rank | Brand | Dawn score |
| --- | --- | --- |
| 1 | [Dexcom](https://dawntrend.com/brand/dexcom) | 56 |
| 2 | [Gilead Sciences](https://dawntrend.com/brand/gilead-sciences) | 50 |
| 3 | [Intuitive Surgical](https://dawntrend.com/brand/intuitive-surgical) | 49 |
| 4 | [GE HealthCare](https://dawntrend.com/brand/ge-healthcare) | 47 |
| 5 | [Idexx Laboratories](https://dawntrend.com/brand/idexx-laboratories) | 47 |
| 6 | [Vertex Pharmaceuticals](https://dawntrend.com/brand/vertex-pharmaceuticals) | 46 |
| 7 | [Alnylam Pharmaceuticals](https://dawntrend.com/brand/alnylam-pharmaceuticals) | 42 |
| 8 | [Amgen](https://dawntrend.com/brand/amgen) | 41 |

## Where do the numbers come from?

Search figures are Google search estimates for the brand and its products. Site figures are third-party traffic estimates. A Dawn score measures attention, not revenue.

See the full Dawn Index.